Investor Overview Recent News Oct 22, 2020 Summary ToggleAgios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020 full article Oct 16, 2020 Summary ToggleAgios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia full article Sep 21, 2020 Summary ToggleAgios Announces Final Overall Survival Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients full article Sep 8, 2020 Summary ToggleAgios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs full article Aug 27, 2020 Summary ToggleAgios to Present at the Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020 full article Aug 6, 2020 Summary ToggleAgios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020 full article View All Events & Presentations Nov 5, 2020 at 8:00 AM EST Q3 2020 Agios Pharmaceuticals Inc Earnings Conference Call Add to Outlook Add to Google Calendar full article Sep 9, 2020 at 9:50 AM EDT Agios at Citi 15th Annual BioPharma Virtual Conference full article Aug 13, 2020 at 1:00 PM EDT Agios at Canaccord 40th Annual Growth Conference full article View All Analyst Coverage Firm Analyst Needham & Company Chad Messer Ph.D. Oppenheimer & Co. Mark Breidenbach Ph.D. Piper Sandler Tyler Van Buren RBC Capital Markets Kennen MacKay Pagination First page First Previous page Previous Page 1 Current page 2 Stock Information Price: Change: Volume: (Common Stock) Data as of Oct 25, 2020 9:43 am EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.
Nov 5, 2020 at 8:00 AM EST Q3 2020 Agios Pharmaceuticals Inc Earnings Conference Call Add to Outlook Add to Google Calendar